2019
DOI: 10.1001/jama.2019.9372
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Use of Bone Turnover Markers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
24
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 21 publications
(26 citation statements)
references
References 10 publications
1
24
0
1
Order By: Relevance
“…As already mentioned in the Introduction of this article, osteoporosis has been increasingly studied over the years as it is a skeletal disease leading to structural deterioration of bone tissue and especially when related fractures occur, it significantly interferes with the quality of life (35)(36)(37). Besides, concern has grown to identify effective strategies for managing osteoporosis.…”
Section: Discussionmentioning
confidence: 99%
“…As already mentioned in the Introduction of this article, osteoporosis has been increasingly studied over the years as it is a skeletal disease leading to structural deterioration of bone tissue and especially when related fractures occur, it significantly interferes with the quality of life (35)(36)(37). Besides, concern has grown to identify effective strategies for managing osteoporosis.…”
Section: Discussionmentioning
confidence: 99%
“…Resorption rate exceeding formation rate leads to osteoporosis, which is manifested as low bone mineral density (BMD) and deteriorated bone microstructures. Bone turnover biomarkers are the landmark substances of biochemical products produced during the ongoing process of bone resorption or bone formation ( Bauer, 2019 ). Bone formation markers, including bone isoforms of alkaline phosphatase (BALP) and osteocalcin (OCN), reflect osteoblast activity, while tartrate-resistant acid phosphatase (TRACP) is considered to reflect amount of osteoclasts ( Fontalis and Eastell, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…Lastly, the clinical relevance of these findings is unclear. Although current guidelines do not include measurement of BTMs to assess need for treatment of osteoporosis (Bauer, ), BTMs have been used to inform treatment strategy and assess conditions that affect bone metabolism (Jain and Camacho, ). The negative association between alcohol and bone formation would be of interest to PLWH concerned about modifiable risk factors for poor bone health.…”
Section: Discussionmentioning
confidence: 99%